Search Within

Yanming Zhang

Formats
  1. Journal Article (95)
  2. Meeting Abstract (89)
  3. Research Letter (11)
  4. Review (3)
  5. Editorial (1)
Groups
  1. Department of Pathology and Laboratory Medicine (199)
  2. Department of Medicine (123)
  3. Center for Hematologic Malignancies (111)
  4. Hematologic Malignancies, Division of (107)
  5. Sloan Kettering Institute Postdocs (73)
  6. GSK Faculty (70)

More Groups

People
  1. Ahmet Dogan (58)
  2. Mikhail Roshal (58)
  3. Maria Arcila (55)
  4. Wenbin Xiao (48)
  5. Martin Tallman (33)
  6. Ross Levine (30)

More People

Years
  1. 2025 (6)
  2. 2024 (24)
  3. 2023 (29)
  4. 2022 (26)
  5. 2021 (25)
  6. 2020 (36)

More Years

Publications
  1. Blood (42)
  2. Modern Pathology (22)
  3. Laboratory Investigation (20)
  4. Blood Advances (11)
  5. Genes Chromosomes and Cancer (7)
  6. Nature Communications (6)

More Publications

Publishers
  1. American Society of Hematology (53)
  2. Nature Publishing Group (35)
  3. Nature Research (23)
  4. Elsevier Inc. (13)
  5. Wiley Blackwell (9)
  6. American Association for Cancer Research (7)

More Publishers

Results (199)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Minimal residual disease (MRD) at time of complete remission is commonly detected in acute myeloid leukemia (AML) patients age ≥ 60 years and significantly impacts outcome based on post-remission treatment strategies: Prospective analysis of ECOG-ACRIN (E-A) E2906 phase III trial
    Meeting Abstract

    Foran, J. M.; Sun, Z.; Paietta, E.; Racevskis, J.; Claxton, D. F.; Lazarus, H. M.; Arber, D. A.; Rowe, J. M.; Altman, J. K.; Al-Kali, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Myeloid/histiocytic neoplasms associated with germ cell tumors harbor shared genetic abnormalities indicating a clonal relationship, unique molecular pathogenesis and cellular origin
    Meeting Abstract

    Ho, C.; Zhang, Y.; Aypar, U.; Yabe, M.; Sen, F.; Arcila, M. E.; Dogan, A.; Petrova-Drus, K.
    Blood (2018)

    Fulltext@MSK | Save
  • FLT3-ITD mutations are prevalent and significantly impact outcome after intensive therapy in elderly adults with acute myeloid leukemia (AML): Analysis of the North American Intergroup E2906 phase III trial in patients age ≥ 60 years
    Meeting Abstract

    Foran, J. M.; Sun, Z.; Paietta, E.; Racevskis, J.; Claxton, D. F.; Lazarus, H. M.; Arber, D. A.; Rowe, J. M.; Godwin, J.; Zhang, Y.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A case of KMT2A-SEPT9 fusion-associated acute megakaryoblastic leukemia
    Journal Article

    Forlenza, C. J.; Zhang, Y.; Yao, J.; Benayed, R.; Steinherz, P.; Ramaswamy, K.; Kessel, R.; Roshal, M.; Shukla, N.
    Cold Spring Harbor Molecular Case Studies (2018)

    Fulltext@MSK | Save
  • A recurrent novel MGA-NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma
    Journal Article

    Diolaiti, D.; Dela Cruz, F. S.; Gundem, G.; Bouvier, N.; Boulad, M.; Zhang, Y.; Chou, A. J.; Dunkel, I. J.; Sanghvi, R.; Shah, M.; more...
    Cold Spring Harbor Molecular Case Studies (2018)

    Fulltext@MSK | Save
  • PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation
    Journal Article

    Xiao, W.; Bharadwaj, M.; Levine, M.; Farnhoud, N.; Pastore, F.; Getta, B. M.; Hultquist, A.; Famulare, C.; Medina, J. S.; Patel, M. A.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save
  • JAK/MAP kinase pathway activation and TP53 mutations in acute leukemia with megakaryocytic and erythroid differentiation
    Journal Article

    Xiao, W.; Rampal, R.; Zhang, Y.; Cimera, R.; Jungbluth, A. A.; Arcila, M.; Roshal, M.; Park, D. C.
    Leukemia (2018)

    Fulltext@MSK | Save
  • Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
    Journal Article

    Ng, S. Y.; Yoshida, N.; Christie, A. L.; Ghandi, M.; Dharia, N. V.; Dempster, J.; Murakami, M.; Shigemori, K.; Morrow, S. N.; Van Scoyk, A.; more...
    Nature Communications (2018)

    Fulltext@MSK | Save
  • Extramedullary plasmablastic transformation of plasma cell myeloma: Clinicopathologic study of 10 cases
    Meeting Abstract

    Jelloul, F. Z.; Bhavsar, T.; Pichardo, J. D.; Yabe, M.; Rao, M.; Zhang, Y.; Dogan, A.; Xiao, W.
    Modern Pathology (2018)

    Fulltext@MSK | Save